(Last updated: September 2021)

Appendix B: Panel Roster and Financial Disclosures

Section Review Group

 
Section Review Group
Member Institution Financial Disclosure
Company Relationship
Lydia Barakat Yale University, School of Medicine None N/A
Thomas Campbell* University of Colorado Denver, School of Medicine None N/A
Ellen Kitchell University of Texas Southwestern Medical School None N/A
Susana Lazarte The University of Texas Southwestern Medical Center Gilead Sciences Research Support (paid to institution)
Rodrigo Mauricio Burgos University of Illinois at Chicago, College of Pharmacy OptumRx Consultant
Merck

Janssen Vaccines & Prevention B.V.

ModernaTX, Inc.
Research Support (paid to institution)
Paul Pham Johns Hopkins University, School of Medicine, Westview Urgent Care Medi Center Gilead Sciences

AbbVie
Equity interest
Gregory Robbins Massachusetts General Hospital AIDS Clinical Trial Group

Leonard Meron Biosciences

Gilead Sciences

Emergent Biosolutions

Biotech USA, Inc.
Research Support (paid to institution)
inVentiv Health Research Support (paid to individual)
Anandi Sheth Emory University, School of Medicine None N/A
William Short University of Pennsylvania, Perlman School of Medicine ViiV Healthcare

Gilead Sciences
Scientific Advisory Board
Ronald Wilcox Health Resources and Services Administration None N/A
* Group lead

Note:
Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting is from July 2021 through July 2022.

 

Download Guidelines